Initial studies suggest that this peptide – a dual activator of incretin and GIP receptors – offers a significant improvement in metabolic management efforts . In contrast to existing therapies, Retatrutide seems to influence food intake and energy expenditure via distinct routes. Although further investigation is required , early results gene